Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
Titel:
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
Auteur:
Choueiri, T.K. Motzer, R.J. Rini, B.I. Haanen, J. Campbell, M.T. Venugopal, B. Kollmannsberger, C. Gravis-Mescam, G. Uemura, M. Lee, J.L. Grimm, M.-O. Gurney, H. Schmidinger, M. Larkin, J. Atkins, M.B. Pal, S.K. Wang, J. Mariani, M. Krishnaswami, S. Cislo, P. Chudnovsky, A. Fowst, C. Huang, B. di Pietro, A. Albiges, L.